Comment on “Comparative risk assessment of cardiovascular and kidney outcomes in patients with type 2 diabetes using cystatin C and creatinine in DECLARE-TIMI 58”
Comment on “Comparative risk assessment of cardiovascular and kidney outcomes in patients with type 2 diabetes using cystatin C and creatinine in DECLARE-TIMI 58”. // American Heart Journal Plus: Cardiology Research and Practice. – URL: https://www.sciencedirect.com/science/article/pii/S2666602226002533?dgcid=rss_sd_all
Comment on “Comparative risk assessment of cardiovascular and kidney outcomes in patients with type 2 diabetes using cystatin C and creatinine in DECLARE-TIMI 58”. American Heart Journal Plus: Cardiology Research and Practice. https://www.sciencedirect.com/science/article/pii/S2666602226002533?dgcid=rss_sd_all
“Comment on “Comparative risk assessment of cardiovascular and kidney outcomes in patients with type 2 diabetes using cystatin C and creatinine in DECLARE-TIMI 58”.” American Heart Journal Plus: Cardiology Research and Practice.
@article{article34184,
title = {Comment on “Comparative risk assessment of cardiovascular and kidney outcomes in patients with type 2 diabetes using cystatin C and creatinine in DECLARE-TIMI 58”},
journal = {American Heart Journal Plus: Cardiology Research and Practice},
url = {https://www.sciencedirect.com/science/article/pii/S2666602226002533?dgcid=rss_sd_all}
}